AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 23, 2015
November 5-9, 2015
Hynes Convention Center, Boston, Massachusetts, USA.
Join us at the 2015 Molecular Targets and Cancer Therapeutics Conference in Boston to hear about Crown Bioscience's Translational Platform for Oncology and Immunotherapeutics using the world's largest collection of PDX in Human Surrogate Trials (HuTrial™) to accelerate the successful translation of novel oncology therapies into the clinic, as well as the most comprehensive range of dedicated in vitro and in vivo services to power your oncology drug discovery projects. With a constantly growing, globally diverse collection of over 2,000 PDX, and 8,000 Tumor tissues, humanised models for immunotherapeutics, and the capacity to run 100s of models in parallel, let's talk about how we can help you accelerate the transition of your lead candidate into the clinic.
Click here to join our mailing list to be kept up to date with the latest on Crown, our models and Translational Platform. For more information about us and our services, contact us today. To arrange a meeting with our scientists in Boston, simply email us today at email@example.com .